These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19841026)
21. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT; Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607 [TBL] [Abstract][Full Text] [Related]
22. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence. Merino J; Planas A; De Moner A; Gasol A; Contreras C; Marrugat J; Vidal-Barraquer F; Clarà A Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):71-6. PubMed ID: 18396072 [TBL] [Abstract][Full Text] [Related]
23. Long-term effect of enhanced external counterpulsation on endothelial function in the patients with intractable angina. Hashemi M; Hoseinbalam M; Khazaei M Heart Lung Circ; 2008 Oct; 17(5):383-7. PubMed ID: 18706862 [TBL] [Abstract][Full Text] [Related]
24. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Holubkov R; Kennard ED; Foris JM; Kelsey SF; Soran O; Williams DO; Holmes DR Am J Cardiol; 2002 May; 89(10):1182-6. PubMed ID: 12008172 [TBL] [Abstract][Full Text] [Related]
25. Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis. Shah SA; Shapiro RJ; Mehta R; Snyder JA Pharmacotherapy; 2010 Jul; 30(7):639-45. PubMed ID: 20575628 [TBL] [Abstract][Full Text] [Related]
26. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals. Sajja V; Dod H; Beto R; Jain AC; Hobbs GR; Finkel MS W V Med J; 2007; 103(3):10-2. PubMed ID: 17849668 [TBL] [Abstract][Full Text] [Related]
27. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA). Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C; Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163 [TBL] [Abstract][Full Text] [Related]
28. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M; Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of repeat enhanced external counterpulsation for refractory angina in patients failing to complete an initial course of therapy. Lawson WE; Barsness G; Michaels AD; Soran O; Kennard ED; Kelsey SF; Hui JC; Cardiology; 2007; 108(3):170-5. PubMed ID: 17085938 [TBL] [Abstract][Full Text] [Related]
31. Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus. Freeman AM; Abbott JD; Jacobs AK; Vlachos HA; Selzer F; Laskey WK; Detre KM; Williams DO J Interv Cardiol; 2006 Dec; 19(6):475-82. PubMed ID: 17107360 [TBL] [Abstract][Full Text] [Related]
32. Effect of enhanced external counterpulsation on medically refractory angina patients with erectile dysfunction. Lawson WE; Hui JC; Kennard ED; Soran O; McCullough PA; Kelsey SF; Int J Clin Pract; 2007 May; 61(5):757-62. PubMed ID: 17493089 [TBL] [Abstract][Full Text] [Related]
33. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Regensteiner JG; Hiatt WR; Coll JR; Criqui MH; Treat-Jacobson D; McDermott MM; Hirsch AT Vasc Med; 2008 Feb; 13(1):15-24. PubMed ID: 18372434 [TBL] [Abstract][Full Text] [Related]
35. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. McDermott MM; Mandapat AL; Moates A; Albay M; Chiou E; Celic L; Greenland P Arch Intern Med; 2003 Oct; 163(18):2157-62. PubMed ID: 14557213 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of enhanced external counterpulsation in patients with left main disease and angina. Lawson WE; Hui JC; Barsness GW; Kennard ED; Kelsey SF; Clin Cardiol; 2004 Aug; 27(8):459-63. PubMed ID: 15346843 [TBL] [Abstract][Full Text] [Related]
37. Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders. Lawson WE; Hui JC; Kennard ED; Barsness G; Kelsey SF; Cardiology; 2005; 103(4):201-6. PubMed ID: 15832028 [TBL] [Abstract][Full Text] [Related]
38. Enhanced External Counterpulsation for the Treatment of Angina With Nonobstructive Coronary Artery Disease. Ashokprabhu ND; Fox J; Henry TD; Schmidt CW; Tierney D; Gallatin J; Alvarez YR; Thompson L; Hamstra M; Shah SA; Quesada O Am J Cardiol; 2024 Jan; 211():89-93. PubMed ID: 37890564 [TBL] [Abstract][Full Text] [Related]
39. Enhanced external counter pulsation (EECP) for refractory angina pectoris (RAP); results from a first case series. Ahmed W; Akhter N; Masood A J Pak Med Assoc; 2010 Aug; 60(8):692-4. PubMed ID: 20726210 [TBL] [Abstract][Full Text] [Related]
40. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR). Michaels AD; Kennard ED; Kelsey SE; Holubkov R; Soran O; Spence S; Chou TM Clin Cardiol; 2001 Jun; 24(6):453-8. PubMed ID: 11403506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]